AcquisitionOther
AVEO PHARMACEUTICALS, INC. acquired AVEO Oncology
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
AVEO PHARMACEUTICALS, INC. -> AVEO Oncology · $15.00
The combination of LG Chems Life Sciences division and AVEO is expected to create a global oncology organization with a robust portfolio of innovative products supported by full capabilities from discovery to clinical, biologics manufacturing and U.S.
Open source record (SEC) ↗